Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-607-2 | CAS number: 993-13-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Methyl phosphonic acid
- Cas Number:
- 993-13-5
- IUPAC Name:
- Methyl phosphonic acid
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Methyl phosphonic acid (MPA)
- Analytical purity: 80 -84 %
- Impurities (identity and concentrations): methyl ester of MP
- Supplier: Prime Organics, Inc. (Woburn, MA)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Charles River Laboratories, Wilmington, MA
- Age at study initiation: about 7 weeks
- Weight at study initiation: 150 to 225 g
- Fasting period before study: over night
- Housing: individually, steel wire mesh cages
- Diet ad libitum
- Water ad libitum
- Acclimation period: yes
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000, 1750, 1500, 1000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: prior to dosing
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 888 mg/kg bw
- 95% CL:
- 1 462 - 2 438
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 005 mg/kg bw
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 760 mg/kg bw
- Mortality:
- At 2000 mg/kg bw all deaths occurred on day 1 of the study. At 1750 mg/kg bw, one female died on day 3, one male on day 2.
No adverse clinical signs were seen in any other dose groups.
2000 mg/kg bw: 4/5 males, 5/5 females (9/10)
1750 mg/kg bw: 1/5 males, 1/5 females (2/10)
1500 mg/kg bw 0/5 males, 0/5 females (0/10)
1000 mg/kg bw 0/5 males, 0/5 females (0/10)
0 mg/kg bw 0/5 males, 0/5 females (0/10) - Clinical signs:
- other: At 2000 mg/kg bw, four males and five females were hypoactive and cold to touch with laboured breathing. In addition, three males and two females were observed with convulsions and one male was observed with tremors and redness around nose/eyes.
- Gross pathology:
- Upon necropsy, all animals treated with 2000 mg/kg bw had at lease one gross lesion noted, including a dilated stomach, (4 m/ 2 f), a dilated small and large intestine (3 m/ 3 f) kidney foci (1 m/ 1 f) and enlarged stomach (3 f). At 1750 mg/kg bw 4 m and 2 f had no gross lesions, 1 m had dilated stomach and dilated intestine filled with yellow liquid. Two females had pigmented ovaries and 1 f had a dilated thin-walled stomach filled with fluid and mucosa. as well as a tan liver focus. Ovary pigmentation was observed in 2 f that had not died and in the male that died the stomach was dilated and fluid-filled, with a thin wall , mucus covering and black pigment. The small intestine was dilated and filled with yellow fluid and the liver exhibited a tan lateral lobe focus. At 1500 mg/kg, one female had bilateral red ovary pigmentation. At 1000 mg/kg no gross lesions were observed.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- LD50 was determined to be 1888 mg/kg bw (females: 1760 mg/kg bw; males: 2005 mg/kg bw).
- Executive summary:
The acute oral toxicity of methylphosphonic acid was evaluated in a study conducted according to guideline EPA.OPPTS 870. 1100. For each treatment group 5 males and five females were randomly assigned to treatment and control groups. Animals were administered the test article or vehicle control via oral gavage following an overnight fasting period. The following doses were used: 2000, 1750, 1500, 1000 mg/kg bw. At 2000 mg/kg bw all deaths occurred on day 1 of the study. At 1750 mg/kg bw, one female died on day 3, one male on day 2. No deaths occurred in any other dose groups. Based on the findings of the study, the LD50 was determined to be 1888 mg/kg bw (females: 1760 mg/kg bw; males: 2005 mg/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.